Anondita Medicare Qualified as Vendor for South African Government Tender

Anondita Medicare Qualified as Vendor for South African Government Tender

Anondita Medicare Qualified as Vendor for South African Government Tender​

Anondita Medicare Limited, an Indian manufacturer, has secured vendor status with local entities in South Africa. The company was qualified under the Transversal Contract RT75-2025, issued by the National Treasury, Republic of South Africa.

The qualification is notable as it follows the successful completion of extensive due diligence, audit processes, and regulatory approvals by the South African Bureau of Standards (SABS). Anondita Medicare holds the SABS Certification (SANS 4074:2017).

The Transversal Contract RT75-2025 establishes a critical procurement framework for public healthcare requirements across South Africa. The contract period for this supply opportunity spans from November 1, 2025, to October 31, 2030.

This vendor qualification represents a significant milestone in the company’s international growth strategy. Upon formal inclusion as a qualified vendor, Anondita Medicare will be eligible to supply products to South African Local Entities awarded under the tender, thereby strengthening its positioning in global public healthcare supply programs.

Commenting on the achievement, Mr. Anupam Ghosh, Managing Director of Anondita Medicare Limited, stated that being qualified under the Transversal Contract RT75-2025 marks an important development. He added that the achievement reflects the company’s manufacturing capabilities, adherence to global quality standards, and successful completion of regulatory and audit processes, reinforcing the company's presence in international markets.

Anondita Medicare Limited operates as an Indian manufacturer of condoms under its flagship brand, 'COBRA.' The company manages its own manufacturing facility and operates using a quality-driven, compliant production model. Led by Mr. Anupam Ghosh, the company is focused on expanding its geographical footprint across India and international markets. Furthermore, initiatives like automation-led capacity enhancement and patented female condom products are supporting the company's long-term growth and value creation goals.

ANONDITA Stock Price Movement​

On Tuesday, Anondita Medicare Limited shares slipped by 4.99% to settle at ₹1074. The stock recorded a total traded volume of 48,000 shares, moving sharply down from the previous day's close of ₹1130.45.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top